ADGM logo

ADAGIO MEDICAL HOLDINGS INC

ADGMNASDAQ
🏆 #5240 by market capEarnings Nov 10US Equity
$0.15▼ $0.01 (−9.15%)
Live
🔔
Track ADGM
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 9.2%
7d▼ 67.8%
14d▼ 66.9%
30d▼ 71.8%
ytd▼ 85.1%
1y▼ 92.7%
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
72
Fair

Trading Snapshot

Day Range
$0.15 – $0.15
52-Week Range
$0.18 – $2.58
Volume
$2.44B
Avg Volume
$2.64B
Shares Outstanding
22.2M
Next Earnings
Oct 27, 2026

Fundamentals Snapshot

Annual Revenue
$616,533
Last Q Revenue
$151,542
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
$-1.44
Dividend Yield
—
Dilution (1yr)
+35.5%

Why Investors Own ADGM

  • ✓High-growth profile — revenue up +11.2% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 72% gross margin and 29% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ADGM logo

ADAGIO MEDICAL HOLDINGS INC

ADGM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▼ −100.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-620.1%▲ +84.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$22M▼ −65.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$19M▼ −37.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
20.1M▲ +35.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$5M▼ −$9M YoY
StockOtter · stockotter.space

About ADAGIO MEDICAL HOLDINGS INC

Adagio Medical Holdings, Inc. is an innovative biotechnology firm dedicated to revolutionizing the treatment of cardiac arrhythmias through advanced medical technologies. Utilizing its proprietary platform, the company is spearheading the development of targeted ablation techniques that address significant unmet needs in the electrophysiology sector. Supported by a robust product pipeline and a seasoned leadership team, Adagio represents an attractive investment opportunity for institutional investors seeking growth in the healthcare space while contributing to improved outcomes in cardiac patient care.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100

Analyst Ratings

ⓘ
Consensus
Buy
9 analysts
Strong Buy2
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
CNBC·2h ago

ADAGIO MEDICAL HOLDINGS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift ADGM price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

ADAGIO MEDICAL HOLDINGS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.